“RIGHT TO TRY” ACT: Individual Patient Treatments

Posted on March 8, 2024 by Dr. David Edward Marcinko MBA MEd CMP™

TO FIX THE FDA APPROVAL’S FLAW

By Staff Reporters

***

***

DEFINITION: Right-to-try laws are United States state laws and a federal law that were created with the intent of allowing terminally ill patients access to experimental therapies (drugs, biologics, devices) that have completed Phase I testing but have not been approved by the Food and Drug Administration (FDA).

Right to Try 2.0 laws could help fix FDA’s approval process; Right to Try for Individualized Treatments. 

This law would allow patients suffering from rare and genetic diseases to try personalized treatments not yet approved by the FDA, as long as they have the support of their physician and have exhausted other treatment options. This policy would have an outsized impact on patients with rare diseases. Although rare diseases have small patient pools by definition, collectively, about 30 million Americans are estimated to have a rare disease.

What’s more, 80% of these rare diseases are genetic in nature, and 95% have no FDA-approved treatment.

COMMENTS APPRECIATED

Thank You

***

***

Filed under: "Doctors Only", Drugs and Pharma, Ethics, Health Economics, Health Insurance, Industry Indignation Index, Information Technology | Tagged: , , , , , | Leave a comment »

DAILY UPDATE: International Women’s Day as Rivian and Stocks Zoom Higher!

Posted on March 8, 2024 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

Stocks surged yesterday, once again pushing the S&P 500 and NASDAQ to record highs, after Fed Chair Jerome Powell said he expects interest rates to come down this year. It was also a big day for Rivian which zoomed 13% after it revealed three new vehicles.

Here’s where the major benchmarks ended:

  • The S&P 500 index rallied 52.60 points (1.0%) to 5,157.36; the Dow Jones Industrial Average gained 130.30 points (0.3%) to 38,791.35; the NASDAQ Composite climbed 241.83 points (1.5%) to 16,273.38.
  • The 10-year Treasury note yield (TNX) lost almost 2 basis points to 4.085%.
  • The CBOE Volatility Index® (VIX) fell 0.06 to 14.44.

Chip-maker strength boosted the Philadelphia Semiconductor Index (SOX) 3.4% to its fourth record close in the past five trading days. The index has gained 9.3% so far this month and 24% for the year. Oilfield services and communication services companies were also among the market’s strongest sectors. Small-cap shares joined the rally, boosting the Russell 2000® Index (RUT) 0.8% to a two-year high.

In other markets, the U.S. dollar index (DXY) slipped 0.5%, its fifth consecutive daily decline, and touched a five-week low. The dollar has been under pressure from expectations for lower U.S. interest rates.

CITE: https://www.r2library.com/Resource

COMMENTS APPRECIATED

Thank You

***

***

Filed under: "Ask-an-Advisor", Breaking News, Drugs and Pharma, Ethics, Experts Invited, Financial Planning, Health Economics, Health Insurance, Healthcare Finance, Investing | Tagged: , , , , , , , , , , , , | Leave a comment »